These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38030079)

  • 81. Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era.
    Niu X; Xue F; Liu P; Hu C; He X
    Int J Med Sci; 2022; 19(2):267-273. PubMed ID: 35165512
    [No Abstract]   [Full Text] [Related]  

  • 82. Long-term effects on carotid intima-media thickness after radiotherapy in patients with nasopharyngeal carcinoma.
    Huang TL; Hsu HC; Chen HC; Lin HC; Chien CY; Fang FM; Huang CC; Chang HW; Chang WN; Huang CR; Tsai NW; Kung CT; Wang HC; Lin WC; Cheng BC; Su YJ; Chang YT; Chang CR; Tan TY; Lu CH
    Radiat Oncol; 2013 Nov; 8():261. PubMed ID: 24196030
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Qi ZY; Liu ZG; Jiang GM; Xu XW; Chen SY; Zhu FT; Zhang WJ; Lawrence WR; Ma J; Zhou GQ; Sun Y
    Radiother Oncol; 2019 Aug; 137():137-144. PubMed ID: 31102988
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Feng Y; Cao C; Hu Q; Chen X
    Cancer Res Treat; 2019 Jul; 51(3):1222-1230. PubMed ID: 30590003
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of Significant Carotid Stenosis for Nasopharyngeal Carcinoma between Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy.
    Liao W; Zhou H; Fan S; Zheng Y; Zhang B; Zhao Z; Xiao S; Bai S; Liu J
    Sci Rep; 2018 Sep; 8(1):13899. PubMed ID: 30224668
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
    Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
    Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma.
    Tuan JK; Ha TC; Ong WS; Siow TR; Tham IW; Yap SP; Tan TW; Chua ET; Fong KW; Wee JT
    Radiother Oncol; 2012 Sep; 104(3):305-11. PubMed ID: 22280806
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
    Xu BQ; Tu ZW; Tao YL; Liu ZG; Li XH; Yi W; Jiang CB; Xia YF
    Chin J Cancer; 2016 Apr; 35():37. PubMed ID: 27056488
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
    Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
    Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients.
    Yang K; Ahn YC; Nam H; Hong SD; Oh D; Noh JM
    Oral Oncol; 2021 Mar; 114():105180. PubMed ID: 33497910
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy and safety of PLDR-IMRT for the re-irradiation of recurrent NPC: A prospective, single-arm, multicenter trial.
    Huang R; Li Z; Yang F; Zhang Y; Jiang Y; Li C; Gao H; Li G; Liu Y; Guo W; Yang D; Zhang S; Li J; Wen H; Lang J; Zhang P
    Cancer Sci; 2023 Jun; 114(6):2534-2543. PubMed ID: 36788727
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA.
    Wang WY; Lin TY; Twu CW; Tsou HH; Lin PJ; Liu YC; Huang JW; Hsieh HY; Lin JC
    Oncotarget; 2016 Jul; 7(27):42608-42616. PubMed ID: 27191654
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
    Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
    Xiang L; Rong JF; Xin-Chen ; Li XY; Zheng Y; Ren PR; Lin S; Wen QL; He LJ; Zhang JW; Shang CL; Yang HR; Fan J; Pang HW; Zhang J; Tan BX; Zhang L; Du XB; Wen SM; Jiang L; Qin G; Wu JB
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):914-924. PubMed ID: 37356553
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012.
    Sun XS; Liu SL; Luo MJ; Li XY; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Liang YJ; Yan JJ; Lin DF; Bi MM; Liu Y; Liang YF; Ma J; Tang LQ; Mai HQ
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):581-590. PubMed ID: 31319091
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
    Yao JJ; Jin YN; Wang SY; Zhang F; Zhou GQ; Zhang WJ; Zhi-Bin ; Cheng ; Ma J; Qi ZY; Sun Y
    BMC Cancer; 2018 Jul; 18(1):740. PubMed ID: 30012115
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Deep radiation-induced ulcer following nasopharyngeal carcinoma: surgical management.
    Hallak B; Morrison M; Kohler R; Bouayed S
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31694827
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prevalence of cancer-related cognitive impairment among patients with nasopharyngeal carcinoma: a cross-sectional study.
    Song S; Hu Q; Du J; Yan S; Lei X; Tang R; Wang C
    Clin Transl Oncol; 2024 Sep; ():. PubMed ID: 39235555
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Progression of cognitive dysfunction in NPC survivors with radiation-induced brain necrosis: A prospective cohort.
    Zhu Y; Cheng J; Li Y; Pan D; Li H; Xu Y; Du Z; Lei M; Xiao S; Shen Q; Shi Z; Tang Y
    Radiother Oncol; 2024 Jan; 190():110033. PubMed ID: 38030079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.